Afro Medicinal Plants a Promising Remedy for Sickle Cell Anemia

N. E. Ahajumobi, J. C. Asika
{"title":"Afro Medicinal Plants a Promising Remedy for Sickle Cell Anemia","authors":"N. E. Ahajumobi, J. C. Asika","doi":"10.9734/ibrr/2024/v15i1332","DOIUrl":null,"url":null,"abstract":"Background: Sickle cell anemia is a disease that affects largely Africans and people in the tropics. It affects an average of 7.74 million and the mortality rate was 376,000 in the year 2021. Sickle cell disease was discovered in 1910 by a Famous scholar Herrick who described it as a hematological (Blood) disease and nearly three decades later, in 1949, Linus Pauling discovered the pathology of sickle cell anemia. Through molecular studies we further learned that sickle cell disease is caused by certain abnormalities in the hemoglobin of the patient, which costs millions of lives, plant products offer hope. \nAims: The objectives were to determine the plants that are in use and the consensus clinical evidence about the plants and sickle cell diseases treatment. To provide easy access to consensus evidence to busy healthcare professionals and to educate the public. \nPlace and Duration of Study: Department of Public Health, College of Health Science, Walden University, Minneapolis, USA, between July 2022 and October 2023. \nMethodology: A systematic review supported by a community approach to intervention services and native medicine theories supported the study. Search engines were Safari, Google, Google scholar, and Firefox. \nResults: Showed that while there were various approaches adopted by modern medicine to provide palliative care for persons with sickle cell diseases, which were directed at raising depleting nutrients, preventing infections and delaying the gelling point of the erythrocyte, no significant achievement has been made at reducing the disease and treating it effectively. Also, over 80% of the patients cannot afford the cost of the treatment. Thankfully, phytochemical compounds isolated from some medicinal plants- Carica papaya, Piper guineense, Cajanus cajan, Zanthoxylum zanthoxyloides, Terminalia catappa L, and formulations made from them such as Niprisan and Ciklavit, which have been approved for use for treating sickle cell diseases stands to be sustainable and efficacious offer hope. Outcome will bring a significant social change in local and global public health and economic activities. \nConclusion: Clinically tested phytochemical compositions of implicated plants, herbal preparations, and specific nutrients investigated in this study possess anti-sickling properties and a couple of the preparations have been approved for sickle cell disease treatment in Nigeria.","PeriodicalId":249518,"journal":{"name":"International Blood Research & Reviews","volume":"175 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Blood Research & Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/ibrr/2024/v15i1332","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Sickle cell anemia is a disease that affects largely Africans and people in the tropics. It affects an average of 7.74 million and the mortality rate was 376,000 in the year 2021. Sickle cell disease was discovered in 1910 by a Famous scholar Herrick who described it as a hematological (Blood) disease and nearly three decades later, in 1949, Linus Pauling discovered the pathology of sickle cell anemia. Through molecular studies we further learned that sickle cell disease is caused by certain abnormalities in the hemoglobin of the patient, which costs millions of lives, plant products offer hope. Aims: The objectives were to determine the plants that are in use and the consensus clinical evidence about the plants and sickle cell diseases treatment. To provide easy access to consensus evidence to busy healthcare professionals and to educate the public. Place and Duration of Study: Department of Public Health, College of Health Science, Walden University, Minneapolis, USA, between July 2022 and October 2023. Methodology: A systematic review supported by a community approach to intervention services and native medicine theories supported the study. Search engines were Safari, Google, Google scholar, and Firefox. Results: Showed that while there were various approaches adopted by modern medicine to provide palliative care for persons with sickle cell diseases, which were directed at raising depleting nutrients, preventing infections and delaying the gelling point of the erythrocyte, no significant achievement has been made at reducing the disease and treating it effectively. Also, over 80% of the patients cannot afford the cost of the treatment. Thankfully, phytochemical compounds isolated from some medicinal plants- Carica papaya, Piper guineense, Cajanus cajan, Zanthoxylum zanthoxyloides, Terminalia catappa L, and formulations made from them such as Niprisan and Ciklavit, which have been approved for use for treating sickle cell diseases stands to be sustainable and efficacious offer hope. Outcome will bring a significant social change in local and global public health and economic activities. Conclusion: Clinically tested phytochemical compositions of implicated plants, herbal preparations, and specific nutrients investigated in this study possess anti-sickling properties and a couple of the preparations have been approved for sickle cell disease treatment in Nigeria.
非洲药用植物有望治疗镰状细胞性贫血
背景:镰状细胞性贫血是一种主要影响非洲人和热带地区居民的疾病。平均有 774 万人患有此病,2021 年的死亡率为 37.6 万。镰状细胞病是 1910 年由著名学者赫里克发现的,他将其描述为一种血液病,近三十年后,即 1949 年,莱纳斯-鲍林发现了镰状细胞贫血的病理。通过分子研究,我们进一步了解到镰状细胞病是由患者血红蛋白的某些异常引起的,它夺去了数百万人的生命,而植物产品则带来了希望。目的:我们的目标是确定正在使用的植物,以及有关植物和镰状细胞病治疗的共识临床证据。为繁忙的医疗保健专业人员提供获取共识证据的便捷途径,并教育公众。研究地点和时间:美国明尼阿波利斯瓦尔登大学健康科学学院公共卫生系,2022 年 7 月至 2023 年 10 月。研究方法:在社区干预服务方法和本土医学理论的支持下进行系统回顾。搜索引擎为 Safari、Google、Google scholar 和 Firefox。结果结果表明,虽然现代医学采取了各种方法为镰状细胞病患者提供姑息治疗,这些方法旨在提高耗竭的营养、预防感染和延缓红细胞的胶凝点,但在减轻病情和有效治疗方面并未取得重大成就。此外,超过 80% 的患者无力承担治疗费用。值得庆幸的是,从一些药用植物中分离出来的植物化学物质--木瓜(Carica papaya)、瓜蒌(Piper guineense)、矢车菊(Cajanus cajan)、Zanthoxylum zanthoxyloides、Terminalia catappa L,以及用这些植物制成的制剂,如 Niprisan 和 Ciklavit,已被批准用于治疗镰状细胞病,具有可持续性和有效性,这给人们带来了希望。其成果将为当地和全球的公共卫生和经济活动带来重大的社会变革。结论经临床测试,本研究中调查的相关植物、草药制剂和特定营养素的植物化学成分具有抗镰状细胞病的特性,其中几种制剂已被批准用于尼日利亚的镰状细胞病治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信